Tempus AI (NASDAQ:TEM) Sees Large Volume Increase - Time to Buy?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 1,217,508 shares traded hands during trading, an increase of 11% from the previous session's volume of 1,095,627 shares.The stock last traded at $40.87 and had previously closed at $49.50.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Stifel Nicolaus initiated coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued a "buy" rating and a $45.00 price target on the stock. TD Cowen initiated coverage on Tempus AI in a research note on Tuesday, July 9th. They issued a "buy" rating and a $50.00 price target for the company. Bank of America cut shares of Tempus AI from a "buy" rating to a "neutral" rating and lifted their target price for the company from $45.00 to $60.00 in a research note on Wednesday, October 2nd. William Blair started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set an "outperform" rating on the stock. Finally, JPMorgan Chase & Co. upped their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the stock an "overweight" rating in a report on Wednesday, August 7th. Two research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Tempus AI has a consensus rating of "Moderate Buy" and a consensus price target of $48.67.

Tempus AI Trading Down 10.1 %

The business has a fifty day moving average price of $50.47. The company has a quick ratio of 3.52, a current ratio of 3.70 and a debt-to-equity ratio of 4.50.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The company had revenue of $165.97 million during the quarter, compared to analysts' expectations of $159.10 million. On average, sell-side analysts expect that Tempus AI, Inc. will post -6.51 EPS for the current year.

Hedge Funds Weigh In On Tempus AI

Large investors have recently made changes to their positions in the company. Vestor Capital LLC bought a new stake in shares of Tempus AI during the 3rd quarter worth approximately $153,000. Sandia Investment Management LP acquired a new position in Tempus AI during the second quarter valued at approximately $136,000. IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new stake in Tempus AI during the third quarter worth $258,000. Clarus Group Inc. acquired a new stake in shares of Tempus AI in the 3rd quarter valued at $283,000. Finally, GSA Capital Partners LLP bought a new position in shares of Tempus AI in the 3rd quarter valued at $306,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.